MeSH term
Frequency | Condition_Probility | Blotting, Western | 5 | 0.0 |
Cell Division | 4 | 0.0 |
*Cell Movement | 3 | 2.0 |
Gene Expression Regulation, Neoplastic | 2 | 0.0 |
*Histone Deacetylases | 21 | 72.0 |
Humans | 37 | 0.0 |
Neoplasm Metastasis | 4 | 0.0 |
Proteins/genetics/*metabolism | 2 | 0.0 |
Proto-Oncogene Proteins c-bcl-2/metabolism | 2 | 0.0 |
RNA, Messenger/metabolism | 3 | 0.0 |
*Repressor Proteins | 27 | 2.0 |
Research Support, Non-U.S. Gov't | 22 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 18 | 0.0 |
Reverse Transcriptase Polymerase Chain Reaction | 7 | 0.0 |
Animals | 20 | 0.0 |
Chromosome Banding | 2 | 0.0 |
*In Situ Hybridization, Fluorescence | 2 | 1.0 |
Molecular Sequence Data | 16 | 0.0 |
Physical Chromosome Mapping | 3 | 0.0 |
Proteins/*genetics | 13 | 0.0 |
Aged | 6 | 0.0 |
Female | 18 | 0.0 |
*Gene Expression Regulation, Neoplastic | 5 | 0.0 |
Male | 11 | 0.0 |
Middle Aged | 6 | 0.0 |
*Neoplasm Invasiveness | 2 | 2.0 |
*Protein Biosynthesis | 2 | 0.0 |
RNA, Messenger/*biosynthesis | 2 | 0.0 |
English Abstract | 2 | 0.0 |
Gene Expression | 4 | 0.0 |
Lymphatic Metastasis | 5 | 0.0 |
Mutation | 4 | 0.0 |
*Nucleoside-Diphosphate Kinase | 3 | 4.0 |
Ovarian Neoplasms/*genetics/metabolism/pathology | 3 | 10.0 |
Proteins/*genetics/metabolism | 2 | 0.0 |
Transcription Factors/*genetics/metabolism | 2 | 0.0 |
Up-Regulation | 2 | 0.0 |
3T3 Cells | 2 | 0.0 |
Base Sequence | 8 | 0.0 |
Comparative Study | 3 | 0.0 |
Mice | 5 | 0.0 |
Neoplasm Metastasis/*genetics | 7 | 11.0 |
*Caenorhabditis elegans Proteins | 3 | 2.0 |
Gene Expression Regulation, Developmental | 2 | 0.0 |
Genes, Homeobox | 2 | 2.0 |
Adult | 3 | 0.0 |
Aged, 80 and over | 2 | 0.0 |
Amino Acid Sequence | 13 | 0.0 |
Cell Nucleus/metabolism | 3 | 0.0 |
Cloning, Molecular | 9 | 0.0 |
Cytoplasm/metabolism | 2 | 0.0 |
Neoplasm Proteins/*metabolism | 2 | 0.0 |
Sequence Homology | 2 | 0.0 |
Transfection | 4 | 0.0 |
Binding Sites | 3 | 0.0 |
DNA, Complementary | 4 | 0.0 |
*DNA-Binding Proteins | 2 | 0.0 |
Hela Cells | 3 | 0.0 |
Histone Deacetylases/*metabolism | 3 | 2.0 |
Jurkat Cells | 2 | 0.0 |
Repressor Proteins/*metabolism | 2 | 1.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 5 | 0.0 |
Proteins/chemistry/*genetics | 2 | 1.0 |
Rats | 9 | 0.0 |
Sequence Homology, Amino Acid | 4 | 0.0 |
Blotting, Northern | 3 | 0.0 |
Cell Line, Tumor | 3 | 0.0 |
Chromatin/metabolism | 5 | 1.0 |
DNA, Complementary/metabolism | 2 | 0.0 |
Estrogen Receptor alpha | 4 | 1.0 |
Models, Genetic | 3 | 0.0 |
Oligonucleotide Array Sequence Analysis | 2 | 0.0 |
Plasmids/metabolism | 2 | 0.0 |
Precipitin Tests | 3 | 0.0 |
Promoter Regions (Genetics) | 4 | 0.0 |
Protein Binding | 4 | 0.0 |
Protein Biosynthesis | 3 | 0.0 |
RNA, Small Interfering/metabolism | 2 | 1.0 |
Receptors, Estrogen/*metabolism | 2 | 0.0 |
Transcription, Genetic | 5 | 0.0 |
Two-Hybrid System Techniques | 2 | 0.0 |
COS Cells | 2 | 0.0 |
Chromatin/genetics | 2 | 6.0 |
Time Factors | 4 | 0.0 |
*Gene Expression Regulation | 2 | 0.0 |
Histones/metabolism | 3 | 1.0 |
Sequence Alignment | 2 | 0.0 |
Esophageal Neoplasms/*metabolism | 2 | 10.0 |
Gene Expression Regulation, Neoplastic/*physiology | 2 | 1.0 |
DNA, Complementary/genetics | 2 | 0.0 |
RNA, Messenger | 2 | 0.0 |
Cell Communication | 2 | 0.0 |
Cell Differentiation | 3 | 0.0 |
Disease Progression | 2 | 0.0 |
Gene Expression Regulation | 2 | 0.0 |
Transcription Factors/metabolism | 2 | 0.0 |
Tumor Cells, Cultured | 5 | 0.0 |
Epithelium/metabolism | 2 | 0.0 |
Histone Deacetylases/metabolism | 3 | 3.0 |
Repressor Proteins/metabolism | 3 | 1.0 |
Immunohistochemistry | 3 | 0.0 |
DNA Primers | 2 | 0.0 |
Neoplasm Invasiveness | 4 | 0.0 |
Polymerase Chain Reaction | 2 | 0.0 |
RNA, Messenger/analysis/biosynthesis | 2 | 0.0 |
RNA, Neoplasm/analysis | 3 | 1.0 |
Acetylation | 2 | 0.0 |
Prognosis | 2 | 0.0 |
Pregnancy | 2 | 0.0 |
Glutathione Transferase/genetics | 2 | 0.0 |
Neoplasm Proteins/*biosynthesis/genetics | 2 | 1.0 |
Proteins/*metabolism | 2 | 0.0 |
